Shu‐Meng Fu
Shandong University(CN)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Antibiotics Pharmacokinetics and Efficacy, Biosimilars and Bioanalytical Methods, Tuberculosis Research and Epidemiology, SARS-CoV-2 and COVID-19 Research
Most-Cited Works
- → Machine Learning Approach in Dosage Individualization of Isoniazid for Tuberculosis(2024)8 cited
- → Machine learning approach for dosage individualization of azithromycin in children with community‐acquired pneumonia(2025)4 cited
- → Population pharmacokinetics and dosing optimization of cefoselis in paediatric patients with haematological malignancies(2025)1 cited
- → 21 A first-in-human phase 1 study of SIM0417, a 3CL-like protease inhibitor for treatment of COVID-19, in healthy adult subjects(2024)
- → Model-informed drug development in public health emergency of international concern: accelerating marketing authorization of simnotrelvir(2025)